Ribavirin Suppliers & Bulk Manufacturers
Available Forms: Tablets, Capsules and Oral Solution
Available Strengths: Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL
Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)
Category:
Hepatitis
Ribavirin is an antiviral used in combination with drugs like Interferon Alfa or Sofosbuvir to treat chronic Hepatitis C. Approved in the US and EU, it’s available in tablet or capsule form under brands like Rebetol® and Copegus®. Ribavirin boosts antiviral response and is essential in genotype-specific HCV treatment plans in pharma B2B.
Ribavirin is available in Tablets, Capsules and Oral Solution
and strengths such as Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ribavirin is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ribavirin can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ribavirin is a broad-spectrum antiviral used in combination with other agents, such as Interferon Alfa or Sofosbuvir, for the treatment of chronic Hepatitis C virus (HCV) infection. Available in oral capsule and tablet forms, Ribavirin enhances antiviral efficacy by inhibiting viral RNA replication. It is commonly prescribed in combination regimens to improve sustained virologic response (SVR) in HCV patients. Ribavirin is FDA and EMA approved and marketed under various brands like Rebetol® and Copegus®. It remains a key product in pharma B2B hepatitis portfolios for both US and EU healthcare markets, particularly in resource-limited or genotype-specific treatment settings.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing